Clinic
Texas Health Harris Methodist Hospital Cleburne
Texas Health Harris Methodist Hospital Cleburne was paid $2.31M by Medicaid between Sep 2020 and Nov 2024, across 54 billing codes. Its largest line is 99284, emergency room visit (serious) — 41% of everything it billed.
33Billing provider infoTEXAS HEALTH HARRIS METHODIST HOSPITAL CLEBURNE
CLEBURNE, TX 76033
CLEBURNE, TX 76033
33aNPI1396778064assigned 07/08/2006
33bProvider typeAmbulatory Surgical Clinic/Center
28Total paid$2.31M
24GClaims55,096
24DCodes billed54
24AFirst – last monthSep 2020 – Nov 2024
Compared with peers
Next to other Ambulatory Surgical Clinic/Center providers in Texas
Rank by total paid#112 of 320
Median peer was paid$205K
This provider vs. median11×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Auditor's notes
Automated statistical signals. Not evidence of fraud — how these are computed.
Entity ProliferationAuthorized official MINCHER, JEFF controls 13+ related entities in our dataset. Read more
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2020 | 986 | $41K | |
| 2021 | 13,137 | $418K | |
| 2022 | 19,593 | $722K | |
| 2023 | 15,800 | $769K | |
| 2024incomplete | 5,580 | $360K |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| 99284 | Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity | 41% | 5,321 | 5,025 | $948K |
| 99283 | Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity | 21% | 8,723 | 8,380 | $490K |
| 87502 | Infectious agent detection by nucleic acid, influenza virus, for multiple types or subtypes, includes all targets | 9.5% | 2,422 | 2,357 | $220K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 4.7% | 2,096 | 2,041 | $108K |
| 99285 | Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life | 4.0% | 894 | 835 | $94K |
| 71045 | Radiologic examination, chest; single view | 3.2% | 2,854 | 2,654 | $74K |
| C9803 | Hospital outpatient clinic visit specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 2.7% | 3,504 | 3,423 | $63K |
| 80053 | Comprehensive metabolic panel | 2.7% | 4,597 | 4,116 | $61K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 1.7% | 5,268 | 4,727 | $40K |
| U0002 | 2019-ncov coronavirus, sars-cov-2/2019-ncov (covid-19), any technique, multiple types or subtypes (includes all targets), non-cdc | 1.5% | 733 | 710 | $35K |
| 99282 | Emergency department visit for the evaluation and management, low to moderate severity | 1.5% | 634 | 620 | $34K |
| 87651 | Infectious agent detection by nucleic acid; Streptococcus, group A, amplified probe | <1% | 698 | 684 | $23K |
42 more codes
| 93005 | Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report | <1% | 1,266 | $23K |
| 87634 | <1% | 226 | $20K | |
| 81003 | <1% | 3,574 | $11K | |
| 70450 | Computed tomography, head or brain; without contrast material | <1% | 235 | $10K |
| 74177 | Computed tomography, abdomen and pelvis; with contrast material | <1% | 63 | $10K |
| 96375 | Therapeutic injection; each additional sequential IV push | <1% | 674 | $6K |
| J7030 | Infusion, normal saline solution , 1000 cc | <1% | 1,899 | $5K |
| CP007 | <1% | 91 | $4K | |
| 84484 | <1% | 955 | $4K | |
| 96374 | Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance | <1% | 766 | $4K |
| 84703 | <1% | 540 | $3K | |
| 83880 | <1% | 221 | $3K | |
| 83690 | <1% | 872 | $2K | |
| 99211 | Office or other outpatient visit for the evaluation and management of an established patient, minimal severity | <1% | 14 | $2K |
| Q9967 | Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml | <1% | 214 | $2K |
| S3620 | Newborn metabolic screening panel, includes test kit, postage and the laboratory tests specified by the state for inclusion in this panel (e.g., galactose; hemoglobin, electrophoresis; hydroxyprogesterone, 17-d; phenylalanine (pku); and thyroxine, total) | <1% | 665 | $2K |
| 99281 | Emergency department visit for the evaluation and management, self-limited or minor | <1% | 30 | $1K |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 78 | $1K |
| 74176 | Computed tomography, abdomen and pelvis; without contrast material | <1% | 12 | $1K |
| 96361 | Intravenous infusion, hydration; each additional hour | <1% | 393 | $736.50 |
| 71046 | Radiologic examination, chest; 2 views | <1% | 13 | $721.78 |
| 59025 | Fetal non-stress test | <1% | 22 | $681.87 |
| 81025 | <1% | 83 | $568.95 | |
| 80307 | Drug test(s), presumptive, any number of drug classes; immunoassay | <1% | 13 | $491.96 |
| J2405 | Injection, ondansetron hydrochloride, per 1 mg | <1% | 954 | $423.59 |
| 96372 | Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular | <1% | 100 | $357.55 |
| 96365 | Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour | <1% | 24 | $331.70 |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 42 | $210.54 |
| J1885 | Injection, ketorolac tromethamine, per 15 mg | <1% | 286 | $166.08 |
| J2270 | Injection, morphine sulfate, up to 10 mg | <1% | 175 | $153.18 |
| 87880 | Infectious agent antigen detection by immunoassay; Streptococcus, group A | <1% | 16 | $140.01 |
| J1100 | Injection, dexamethasone sodium phosphate, 1 mg | <1% | 72 | $119.77 |
| 85610 | <1% | 32 | $100.26 | |
| 83605 | <1% | 39 | $69.08 | |
| 88720 | <1% | 14 | $66.51 | |
| 83735 | <1% | 18 | $46.84 | |
| 81001 | <1% | 13 | $33.37 | |
| Q0162 | Ondansetron 1 mg, oral, fda approved prescription anti-emetic, for use as a complete therapeutic substitute for an iv anti-emetic at the time of chemotherapy treatment, not to exceed a 48 hour dosage regimen | <1% | 25 | $26.59 |
| 36415 | Collection of venous blood by venipuncture | <1% | 1,187 | $20.48 |
| 85379 | <1% | 13 | $17.10 | |
| A9270 | Non-covered item or service | <1% | 1,411 | $1.80 |
| J0131 | Injection, acetaminophen, not otherwise specified,10 mg | 0% | 12 | $0.00 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialMINCHER, JEFF (SENIOR VP REVENUE CYCLE)
| Provider | Location | Paid |
|---|---|---|
| Texas Health Harris Methodist Hospital Fort Worth | Fort Worth, TX | $13.83M |
| Texas Health Arlington Memorial Hospital | Arlington, TX | $8.23M |
| Texas Health Presbyterian Hospital Dallas | Dallas, TX | $5.33M |
| Texas Health Harris Methodist Hospital Southwest Fort Worth | Fort Worth, TX | $5.20M |
| Texas Health Presbyterian Hospital Kaufman | Kaufman, TX | $4.09M |
| Texas Health Presbyterian Hospital Denton | Denton, TX | $3.84M |
| Texas Health Harris Methodist Hospital Stephenville | Stephenville, TX | $3.69M |
| Texas Health Harris Methodist Hospital Hurst-Euless-Bedford | Bedford, TX | $3.57M |
| Texas Health Presbyterian Hospital Plano | Plano, TX | $2.32M |
| Texas Health Harris Methodist Hospital Azle | Azle, TX | $2.14M |
| Texas Health Harris Methodist Hospital Alliance | Fort Worth, TX | $986K |
| Texas Health Presbyterian Hospital Allen | Allen, TX | $965K |
| Texas Health Hospital Frisco | Frisco, TX | $473K |
Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.